| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/16/2014 | WO2014009794A1 Compounds and methods for treating hiv |
| 01/16/2014 | WO2014009495A1 Antiproliferative benzo [b] azepin- 2 - ones |
| 01/16/2014 | WO2014009447A1 ARYL SULTAM DERIVATIVES AS RORc MODULATORS |
| 01/16/2014 | WO2014009425A1 Inhibition of enzymes |
| 01/16/2014 | WO2014009302A1 Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection |
| 01/16/2014 | WO2014009295A1 Imidazopyridine derivatives as modulators of tnf activity |
| 01/16/2014 | WO2014009219A1 Method for preparing substituted triazolopyridines |
| 01/16/2014 | WO2013177559A3 Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators |
| 01/16/2014 | US20140018540 Casein kinase 1delta (ck 1delta) inhibitors |
| 01/16/2014 | US20140018533 Novel furanone derivative |
| 01/16/2014 | US20140018384 Quinolinone derivatives for use in the treatment of an autoimmune disease and/or an inflammatory disease |
| 01/16/2014 | US20140018380 Bicyclic heteroaryl compounds as gpr119 receptor agonists |
| 01/16/2014 | US20140018370 Apoptosis signal-regulating kinase inhibitors |
| 01/16/2014 | US20140018364 Chemical compounds |
| 01/16/2014 | US20140018360 Azaindenoisoquinoline topoisomerase i inhibitors |
| 01/16/2014 | US20140018356 Fused cyclopentyl antagonists of ccr2 |
| 01/16/2014 | US20140018347 BENZOXAZEPINES AS INHIBITORS OF mTOR AND METHODS OF THEIR USE AND MANUFACTURE |
| 01/16/2014 | US20140018345 Inhibition of enzymes |
| 01/16/2014 | US20140018344 Azaindole derivatives |
| 01/16/2014 | US20140018319 Imidazotriazinecarbonitriles useful as kinase inhibitors |
| 01/16/2014 | DE102012006903A9 Neue aromatische Heterocyclen, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend neue aromatische Heterocyclen New aromatic heterocycles, to processes for their preparation and medicines containing novel aromatic heterocycles |
| 01/16/2014 | CA2877550A1 Imidazopyridine derivatives as modulators of tnf activity |
| 01/16/2014 | CA2877445A1 Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection |
| 01/16/2014 | CA2877187A1 Antiproliferative benzo [b]azepin-2-ones |
| 01/16/2014 | CA2876449A1 Aryl sultam derivatives as rorc modulators |
| 01/16/2014 | CA2876370A1 Compounds and methods for treating hiv |
| 01/15/2014 | EP2684880A1 Dispiropyrrolidine derivative |
| 01/15/2014 | EP2684879A1 Substituted mesoionic compounds for combating animal pests |
| 01/15/2014 | EP2683718A1 Thiocyanato or isothiocyanato substituted naphthalene diimide and rylene diimide compounds and their use as n-type semiconductors |
| 01/15/2014 | EP2683717A1 Preparation of 3-[2-[4-((6-fluoro-1, 2-benzisoxazol-3-yl)-l-piperidinyl)-6, 7, 8, 9-tetrahydro-9-hydroxy-2-methyl-4h-pyrido[ 1, 2-a]-pyrimidin-4-one (paliperidone) and paliperidone palmitate. |
| 01/15/2014 | EP2683716A1 Pyrido[3,4-b]pyrazine derivatives as syk inhibitors |
| 01/15/2014 | EP2683715A1 Pyrido [2, 3 - b]pyrazine derivatives and their therapeutical uses |
| 01/15/2014 | EP2683693A1 Rorgammat inhibitors |
| 01/15/2014 | EP2683244A1 Heterocyclic modulators of lipid synthesis |
| 01/15/2014 | CN103517903A Pyrrolopyridineamino derivatives as MPS1 inhibitors |
| 01/15/2014 | CN103517902A Methods and compositions for treating beta-thalassemia and sickle cell disease |
| 01/15/2014 | CN103517898A Novel 3-hydroxyisothiazole 1-oxide derivative |
| 01/15/2014 | CN103509029A Phenanthroquinolizidine alkaloid derivatives and salts thereof, and preparation, anti-plant virus activity and anti-cancer activity of phenanthroquinolizidine alkaloid derivatives and salts thereof |
| 01/15/2014 | CN103509021A Cytisine derivative, its preparation method and anticancer effect research |
| 01/15/2014 | CN103509020A Synthetic method of mirtazapine |
| 01/15/2014 | CN103509019A Dibenzocoronene compound and preparation method thereof |
| 01/15/2014 | CN103509018A Synthesis method and application of phenanthroline copper complex |
| 01/15/2014 | CN103509017A Substituted pyrazolo[1,5-a]pyrimidine compounds as TRK kinase inhibitors |
| 01/15/2014 | CN103509016A Bipyridine fluorene derivatives, preparation method and application thereof, and electroluminescent device |
| 01/15/2014 | CN103509015A Salts of 14-hydroxyantofine derivative |
| 01/15/2014 | CN103509014A Salts of antofine derivatives |
| 01/15/2014 | CN103509013A Salts of delta 11,12-antofine derivatives |
| 01/15/2014 | CN103509012A Phenanthroindolizidine alkaloid C14-site aminated derivatives, and preparation and anti-plant virus activity thereof |
| 01/15/2014 | CN103509011A 1-(4-hydroxy-3-formyl amino acid-phenyl)-beta-carboline, preparation method thereof, anti-inflammatory and antitumor activities thereof, and application thereof |
| 01/15/2014 | CN103509010A Organic light-emitting compound and organic light-emitting device including the same |
| 01/15/2014 | CN103508930A Bis(aminodithioformate)-1,3-propane diester compound, and synthesis method, pharmaceutical composition and use thereof |
| 01/15/2014 | CN103508835A Indene benzophenanthrene derivative and organic light-emitting device using same |
| 01/15/2014 | CN102276514B Fluorene-bridged blue phosphorescent main body material and preparation method and application thereof |
| 01/15/2014 | CN102250203B Beta-carboline aminoacid benzyl ester, preparation method and application thereof |
| 01/15/2014 | CN101723936B Kinase suppressor and pharmaceutical application thereof |
| 01/14/2014 | US8629276 Inhibitors of human immunodeficiency virus replication |
| 01/14/2014 | US8629275 AHCY hydrolase inhibitors for treatment of hyper homocysteinemia |
| 01/14/2014 | US8629158 Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof |
| 01/14/2014 | US8629137 CGRP antagonists |
| 01/14/2014 | US8628975 Methods and kits using extended rhodamine dyes |
| 01/14/2014 | US8628863 Indenopyrene compound and organic light-emitting device using the compound |
| 01/14/2014 | CA2624491C Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia |
| 01/14/2014 | CA2578741C 1-alkoxy 1h-imidazo ring systems and methods |
| 01/09/2014 | WO2014008270A1 Solid state form of vemurafenib choline salt |
| 01/09/2014 | WO2014008197A1 Heterocyclic modulators of lipid synthesis |
| 01/09/2014 | WO2014007951A2 Substituted tricyclic compounds as fgfr inhibitors |
| 01/09/2014 | WO2014007287A1 Light emitting elment material and light emitting element |
| 01/09/2014 | WO2014007228A1 Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes |
| 01/09/2014 | WO2014006604A1 Novel solid forms of phosphodiesterase type 5 inhibitors |
| 01/09/2014 | WO2014006554A1 3-(PYRAZOLYL)-1H-PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS KINASE INHIBITORS |
| 01/09/2014 | WO2013164839A8 Amorphous form of apixaban, process of preparation and compositions thereof |
| 01/09/2014 | WO2012135944A9 Protein kinase inhibitors |
| 01/09/2014 | US20140011997 Neprilysin inhibitors |
| 01/09/2014 | US20140011989 Paa nanoparticles for tumor treatment and imaging |
| 01/09/2014 | US20140011835 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases |
| 01/09/2014 | US20140011810 Compounds that Modulate EGFR Activity and Methods for Treating or Preventing Conditions Therewith |
| 01/09/2014 | US20140011807 Nitrogen-containing saturated heterocyclic compound |
| 01/09/2014 | US20140011806 Pyrazole derivatives as erk inhibitors |
| 01/09/2014 | US20140011796 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
| 01/09/2014 | US20140011795 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
| 01/09/2014 | US20140011777 Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| 01/09/2014 | US20140011775 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 01/09/2014 | US20140011770 Compositions and methods for inhibition of the jak pathway |
| 01/09/2014 | US20140010892 Benzimidazole derivatives and their use as protein kinase inhibitors |
| 01/09/2014 | US20140010867 Treatment of proliferative disorders with a chemiluminescent agent |
| 01/09/2014 | CA2878360A1 Novel solid forms of phosphodiesterase type 5 inhibitors |
| 01/09/2014 | CA2877999A1 Heterocyclic modulators of lipid synthesis |
| 01/09/2014 | CA2876689A1 Substituted tricyclic compounds as fgfr inhibitors |
| 01/08/2014 | EP2682393A1 Inhibitors of HCV NS5A comprising a bicyclic core. |
| 01/08/2014 | EP2682120A1 Stable laquinimod preparations |
| 01/08/2014 | EP2681217A1 Perylene-based semiconducting materials |
| 01/08/2014 | EP2681216A2 Substituted 6,5-fused bicyclic heteroaryl compounds |
| 01/08/2014 | EP2681215A1 Serine/threonine kinase inhibitors |
| 01/08/2014 | EP2681214A1 Bridged piperidine derivatives |
| 01/08/2014 | EP2681206A1 Mst1 kinase inhibitors and methods of their use |
| 01/08/2014 | EP2681191A1 2-acyloxy-pyrrolin-4-ones |
| 01/08/2014 | EP2680887A1 Dipyridinium derivatives |
| 01/08/2014 | EP2680852A1 Pharmaceutically active disubstituted triazine derivatives |
| 01/08/2014 | EP2680694A1 Histone deacetylase inhibitors |
| 01/08/2014 | CN103502247A 7-azaindole derivatives |